Why the study?
The incidence of stroke and/or systemic thromboembolism had not been properly evaluated in well-anticoagulated AF patients.
Does contemporary management with high rates of oral anticoagulation reduce the incidence of stroke and systemic thromboembolism compared to an OAC-naive cohort in Korean patients with non-valvular atrial fibrillation?
Does contemporary management with high rates of oral anticoagulation reduce the incidence of stroke and systemic thromboembolism compared to an OAC-naive cohort in Korean patients with non-valvular atrial fibrillation?
Contemporary well-anticoagulated Korean AF patients have a substantially lower stroke rate compared to OAC-naive patients, and female sex is not associated with an increased risk of stroke/SSE in this treated population.
Answers are grounded in this paper and cite their sources.
Low SSE rates in well-anticoagulated AF support ongoing OAC; leaves open CHA2DS2-VASc discrimination and generalizability.
The incidence of stroke and/or systemic thromboembolism (SSE) has not been properly evaluated in well-anticoagulated atrial fibrillation (AF) patients. This study investigated the incidence of SSE according to CHA2DS2-VASc score in contemporary well-anticoagulated Korean AF patients. Materials and Methods: From the prospective multicenter COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry, we identified 9503 patients with non-valvular AF (mean age, 688 years; female 35.5%) enrolled between June 2016 and May 2020 with eligible follow-up visits. Stroke incidence in the CODE-AF registry was compared with that in an oral anticoagulant (OAC)-nave AF cohort from the Korean National Health Insurance database. Results: The usage rates of OACs and antiplatelet agents were 73.5% (non-vitamin K OACs, 56.4%; warfarin, 17.1%) and 23.8%, respectively. During a mean follow-up period of 26.39.6 months, 163 (0.78 per 100 person-years) patients had SSE. The incidence rate (per 100 person-years) of SSE was 0.77 in the total population, 0.26 in low-risk patients [CHA2DS2-VASc score 0 (male) or 1 (female)], and 0.88 in high-risk patients (CHA2DS2-VASc score 2). Contemporary AF patients had a stroke rate that was about one-fifth the stroke rate reported in a Korean OAC-nave AF cohort. In this cohort, most risk factors for CHA2DS2-VASc score showed significant associations with SSE. Female sex was not associated with an increased risk of stroke/SSE in well-anticoagulated AF patients. Conclusion: Contemporary AF patients have a stroke rate about one-fifth that in OAC-nave AF patients and exhibit different stroke risk factors.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: